Friday, Sept. 18, 2015, 49 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $23.60 to $6,253,037.92.

Highlighted Stocks Traded by Insiders:

SCYNEXIS (SCYX) - FREE Research Report

Angulo Gonzalez David, who is Chief Medical Officer at SCYNEXIS, bought 3,000 shares at $7.00 on Sept. 18, 2015. Following this transaction, the Chief Medical Officer owned 3,000 shares meaning that the stake was boosted by 100% with the 3,000-share transaction.

The shares most recently traded at $7.02, up $0.02, or 0.28% since the insider transaction. Historical insider transactions for SCYNEXIS go as follows:

  • 4-Week # shares bought: 77,267
  • 12-Week # shares bought: 77,267
  • 24-Week # shares bought: 77,267

The average volume for SCYNEXIS has been 20,200 shares per day over the past 30 days. SCYNEXIS has a market cap of $95.9 million and is part of the health care sector and drugs industry. Shares are down 27.45% year-to-date as of the close of trading on Friday.

SCYNEXIS, Inc., a pharmaceutical company, engages in the discovery, development, and commercialization of anti-infectives to address unmet therapeutic needs. Currently, there is 1 analyst who rates SCYNEXIS a buy, no analysts rate it a sell, and none rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on SCYX - FREE

TheStreet Quant Ratings

rates SCYNEXIS as a

sell

. The company's weaknesses can be seen in multiple areas, such as its feeble growth in its earnings per share, deteriorating net income, weak operating cash flow and generally disappointing historical performance in the stock itself. Get the full

SCYNEXIS Ratings Report

from

TheStreet Quant Ratings

now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

Perry Ellis International (PERY) - FREE Research Report

Silverstein Stanley P, who is Pres-Int'l Dev & Global Lic at Perry Ellis International, sold 15,875 shares at $24.03 on Sept. 18, 2015. Following this transaction, the Pres-Int'l Dev & Global Lic owned 79,674 shares meaning that the stake was reduced by 16.61% with the 15,875-share transaction.

The shares most recently traded at $23.89, down $0.14, or 0.58% since the insider transaction. Historical insider transactions for Perry Ellis International go as follows:

  • 4-Week # shares sold: 5,245
  • 12-Week # shares sold: 5,245
  • 24-Week # shares sold: 33,864

The average volume for Perry Ellis International has been 118,000 shares per day over the past 30 days. Perry Ellis International has a market cap of $373.2 million and is part of the consumer goods sector and consumer non-durables industry. Shares are down 9.02% year-to-date as of the close of trading on Friday.

Perry Ellis International, Inc. designs, sources, markets, and licenses apparel products. The company has a P/E ratio of 9.0. Currently, there are 2 analysts who rate Perry Ellis International a buy, no analysts rate it a sell, and 2 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on PERY - FREE

TheStreet Quant Ratings

rates Perry Ellis International as a

hold

. The company's strengths can be seen in multiple areas, such as its solid stock price performance, increase in net income and revenue growth. However, as a counter to these strengths, we also find weaknesses including disappointing return on equity and weak operating cash flow. Get the full

Perry Ellis International Ratings Report

from

TheStreet Quant Ratings

now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

Tiptree Financial (TIPT) - FREE Research Report

Barnes Michael Gene, who is Executive Chairman at Tiptree Financial, bought 5,000 shares at $7.19 on Sept. 18, 2015. Following this transaction, the Executive Chairman owned 3.1 million shares meaning that the stake was boosted by 0.16% with the 5,000-share transaction.

The shares most recently traded at $7.18, down $0.01, or 0.14% since the insider transaction. Historical insider transactions for Tiptree Financial go as follows:

  • 4-Week # shares bought: 38,560
  • 12-Week # shares bought: 100,331
  • 24-Week # shares bought: 309,108

The average volume for Tiptree Financial has been 81,200 shares per day over the past 30 days. Tiptree Financial has a market cap of $237.8 million and is part of the financial sector and insurance industry. Shares are down 16.3% year-to-date as of the close of trading on Friday.

TipTree Financial Inc., formerly Care Investment Trust, operates as a real estate investment trust (REIT). It engages in originating and acquiring healthcare-related real estate and commercial mortgage debt. The stock currently has a dividend yield of 1.4%.

Exclusive Offer: Get the latest Stock Analysis on TIPT - FREE

TheStreet Quant Ratings

rates Tiptree Financial as a

sell

. The company's weaknesses can be seen in multiple areas, such as its generally high debt management risk, disappointing return on equity, weak operating cash flow, poor profit margins and generally disappointing historical performance in the stock itself. Get the full

Tiptree Financial Ratings Report

from

TheStreet Quant Ratings

now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.